Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma
The DOI matches its Crossref record; 46 of the 48 references it cites were found in a registry or an index.
Abstract
Retinoblastoma clinical observations revealed the role of tumor suppressor genes in human cancer, Knudson's 'two-hit' model of cancer induction. We now demonstrate that loss of both RB1 tumor suppressor gene alleles initiates quiescent RB1(-/-) retinomas with low level genomic instability and high expression of the senescence-associated proteins p16(INK4a) and p130. Although retinomas can remain unchanged throughout life, highly proliferative, clonal and aneuploid retinoblastomas commonly emerge, exhibiting altered gene copy number and expression of oncogenes (MYCN, E2F3, DEK, KIF14 and MDM4) and tumor suppressor genes (CDH11, p75(NTR)) and reduced expression of p16(INK4a) and p130. We suggest that RB1 inactivation in developing retina induces genomic instability, but senescence can block transformation at the stage of retinoma. However, stable retinoma is rarely clinically observed because progressive genomic instability commonly leads to highly proliferative retinoblastoma.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“it is well-accepted that loss of RB is the initiating event in these familial retinal tumours, as well as in sporadic cases15–17.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [17]
In the citing paper
“It has been suggested that this type of chromosomal instability is linked to the progression of benign eye lesions to malignant retinoblastoma17.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [17]
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma
Friend, S. H., Bernards, R., Rogelj, S., Weinberg, R. A., Rapaport, J. M., Albert, D. M., & Dryja, T. P. (1986) · Nature · doi:10.1038/323643a0 · Cited by 2,948
Senescence in premalignant tumours
Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A. J., Barradas, M., Benguría, A., Zaballos, A., Flores, J. M., Barbacid, M., et al. (2005) · Nature · doi:10.1038/436642a · Cited by 1,482
Oncogene-induced senescence as an initial barrier in lymphoma development
Braig, M., Lee, S., Loddenkemper, C., Rudolph, C., Peters, A. H. F. M., Schlegelberger, B., Stein, H., Dörken, B., Jenuwein, T., & Schmitt, C. A. (2005) · Nature · doi:10.1038/nature03841 · Cited by 1,220
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
Hernando, E., Nahlé, Z., Juan, G., Diaz-Rodriguez, E., Alaminos, M., Hemann, M., Michel, L., Mittal, V., Gerald, W., Benezra, R., et al. (2004) · Nature · doi:10.1038/nature02820 · Cited by 562
The natural history of incidentally detected small renal masses
Volpe, A., Panzarella, T., Rendon, R. A., Haider, M. A., Kondylis, F. I., & Jewett, M. A. S. (2004) · Cancer · doi:10.1002/cncr.20025 · Cited by 526
Improved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C. A., Glenn, G. M., Zbar, B., Humphrey, J. S., Choyke, P. L., Walther, M. M., Pack, S., Hurley, K., Andrey, C., Klausner, R. D., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<431::aid-humu10>3.0.co;2-y · Cited by 477
Chemotherapy With Focal Therapy Can Cure Intraocular Retinoblastoma Without Radiotherapy
Gallie, B. L. (1996) · Archives of Ophthalmology · doi:10.1001/archopht.1996.01100140521001 · Cited by 416
Self-citation
Research works printed but not linked: 2
- Radnot, 1977, [Elements of photoreceptors in retinoblastomas (author's transl)], Albrecht Von Graefes Arch. Klin. Exp. Ophthalmol., 202, 63
- Yilmaz, 1998, Twelve novel RB1 gene mutations in patients with hereditary retinoblastoma. Mutations in brief no. 206. Online, Hum. Mutat., 12, 434, 10.1002/(SICI)1098-1004(1998)12:6<434::AID-HUMU16>3.0.CO;2-7 · DOI · Paper page
Cited by
Items 201–300 of 349
Epithelial cell adhesion molecule expression in pituitary adenomas: an immunohistochemical study
Ortíz-Plata, A., Moreno-Leyva, K., Lopez-Gómez, M., Santos-Salinas, S., Sánchez-García, A. D. C., & Tena‐Suck, M. L. (2010) · Annals of Diagnostic Pathology · doi:10.1016/j.anndiagpath.2010.06.008 · Cited by 6
“There is a report of the association of Ep-CAM expression with proliferative activity in gastric cancer [39] and in retinoblastoma tumors [40].”
BackgroundBigh3 silencing increases retinoblastoma tumor growth in the murine SV40-TAg-Rb model
Allaman-Pillet, N., Oberson, A., & Schorderet, D. F. (2017) · Oncotarget · doi:10.18632/oncotarget.14659 · Cited by 8
Clinical and magnetic resonance imaging features of 14 patients with trilateral retinoblastoma
Gui, T., Zheng, H. W., Liu, M., Xia, Z., Ji, X., Yin, Q., Wang, D., Li, Y., & Chen, S. (2021) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-605 · Cited by 6
“As the most common intraocular childhood malignancy, RB has a prevalence of 1 in 18,000 (1-4,9,18-20).”
BackgroundKif14: A Clinically Relevant Kinesin and Potential Target for Cancer Therapy
Thériault, B. L., & Corson, T. W. (2015) · Springer eBooks · doi:10.1007/978-94-017-9732-0_10 · Cited by 10
Self-citationCastelino‐Prabhu, S., Stoll, L. M., & Li, Q. K. (2009) · Diagnostic Cytopathology · doi:10.1002/dc.21252 · Cited by 6
González‐Ruiz, I., Samayoa‐Descamps, V., Guagua-Cortez, K. A., González‐Moles, M. Á., & Ramos‐García, P. (2025) · Cancers · doi:10.3390/cancers17152427 · Cited by 6
Genetics of Retinoblastoma: An Overview and Significance of Genetic Testing in Clinical Practice
Abu‐Amero, K. K., Kondkar, A. A., Almontashiri, N. A. M., Khan, A. M., Maktabi, A. M., Hameed, S., & Al-Mesfer, S. (2025) · Genes · doi:10.3390/genes16091031 · Cited by 5
“Loss of functional RB1 primarily leads to the development of retinoblastoma [10,16].”
Borah, N. A., Mittal, R., Sucharita, S., Rath, S., Kaliki, S., Patnaik, S., Tripathy, D., & Reddy, M. M. (2024) · American Journal Of Pathology · doi:10.1016/j.ajpath.2024.05.006 · Cited by 5
Identification of novel genes by targeted exome sequencing in Retinoblastoma
Bisht, S., Chawla, B. V., Kumar, A., Viswanathan, V., Kumar, M., Sharma, P., & Dada, R. (2022) · Ophthalmic Genetics · doi:10.1080/13816810.2022.2106497 · Cited by 5
“Additional genomic alterations in the putative oncogenes (MDM4, KIF14, MYCN, DEK, and E2F3) and potential tumor suppressor gene (CDH11 and NGFR) serve as essential drivers for RB oncogenesis (Table 1 enlists the genes that are drivers in RB progression) (6).”
EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target
Lin, Z., Tang, L., Chen, S., Zhang, W., Lin, J., Gao, H., & Zhang, P. (2023) · Ophthalmic Research · doi:10.1159/000531530 · Cited by 5
Two masquerade presentations of retinoblastoma
Lembo, A., Pichi, F., Santangelo, E., Carrai, P., Hadjistilianou, T., Serafino, M., & Nucci, P. (2015) · International Ophthalmology · doi:10.1007/s10792-015-0134-y · Cited by 5
Xie, Y., Xu, X., & Wei, W. (2021) · Risk Management and Healthcare Policy · doi:10.2147/rmhp.s322373 · Cited by 5
Manukonda, R., Pujar, A., Ramappa, G., Vemuganti, G. K., & Kaliki, S. (2021) · Ophthalmic Genetics · doi:10.1080/13816810.2021.1989602 · Cited by 5
“Eyes with extra-ocular tumor extension 1 (2) 2 (5) .”
BackgroundBowen, R. C., Stathopoulos, C., Munier, F. L., & Singh, A. D. (2019) · Springer eBooks · doi:10.1007/978-3-030-11123-6_8 · Cited by 5
del Río, N. R., Gómez, J. M. A., de la Rosa, F. J. A. G., Calvo, J. M. P., & Martin, A. (2014) · Archivos de la Sociedad Española de Oftalmología (English Edition) · doi:10.1016/j.oftale.2014.02.006 · Cited by 5
Role of B lymphoma Mo-MLV insertion region 1 in the oncogenic behavior of retinoblastomas.
Ren, R., Liu, W., Huang, L., Liu, D. T. L., Choy, K. W., Shi, J., Zhao, J., Zhao, B., Guan, M. Y., Shields, C. L., et al. (2013) · PubMed Central · Cited by 5
Pathology of the Retina and Vitreous
Wilson, D. J., Sahel, J., Brini, A., & Albert, D. M. (2020) · Springer eBooks · doi:10.1007/978-3-319-90495-5_133-1 · Cited by 5
Eintracht, J., Owen, N., Harding, P., & Moosajee, M. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.05.001 · Cited by 4
Learning About Retinoblastoma from Mouse Models That Missed
Cobrinik, D. E. (2012) · Neuromethods · doi:10.1007/7657_2011_25 · Cited by 4
Advances in the role of autophagy in the development of retinoblastoma (Review)
Wan, T., Fu, M., Wu, Z., Gao, X. J., & Zhou, S. (2021) · Oncology Letters · doi:10.3892/ol.2021.12893 · Cited by 4
“Furthermore, the cell regions of RC have higher genetic stability than those of RB (46).”
BackgroundDiverse mutational spectrum in the 13q14 chromosomal region in a Brazilian cohort of retinoblastoma
Mendonça, V., Sena, P. P., dos Santos, A. C. E., Bonvicino, C. R., Ashton‐Prolla, P., Epelman, S., Ferman, S., Lapunzina, P. D., Nevado, J. B., Grigorovski, N. D. A. K., et al. (2022) · Experimental Eye Research · doi:10.1016/j.exer.2022.109211 · Cited by 4
Updates in ophthalmic pathology
Grossniklaus, H., & Mendoza, P. R. (2017) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_49_16 · Cited by 4
“However, it has been shown that both copies of the RB1 gene are also lost in the benign tumor retinocytoma[26] and it is now believed that additional mutations in other genes besides RB1 are required for malignant transformation into retinoblastoma.”
BackgroundRetinoblastom und Retinozytom (Retinom)
Metz, K. A., Westerwick, D., Driever, F., Schmid, K. W., & Guin, C. H. D. L. (2017) · Der Pathologe · doi:10.1007/s00292-017-0384-8 · Cited by 4
López-Ansio, M., Ramos‐García, P., & González‐Moles, M. Á. (2025) · Cancers · doi:10.3390/cancers17020329 · Cited by 4
“The most representative evidence of the importance of loss of pRb function in tumor initiation has been obtained through the genetic study of family members with an inherited alteration in the RB gene alleles that predisposes them to the development of familial retinoblastoma [8–10].”
Streffer, C. (2015) · Research and Reports in Biology · doi:10.2147/rrb.s72016 · Cited by 5
“Table 3 shows such syndromes are ataxia telangiectasia,(10,27,30) Bloom’s syndrome,(10) Fanconi anemia,(10,28,30,31) Li–Fraumeni syndrome,(10,29,30,32) neurofibromatosis, Nijmegen breakage syndrome,(27,30,36) and retinoblastoma.(30,37) Further syndromes caused by the genetic disposition have been described in the text…”
New Hopes in Retinoblastoma Treatment
Turhan, S. A. (2014) · International Journal of Hematology and Oncology · doi:10.4999/uhod.14222 · Cited by 4
Malignant transformation of retinocytoma treated with intra-arterial chemotherapy
Kıratlı, H., & Koç, İ. (2016) · Canadian Journal of Ophthalmology · doi:10.1016/j.jcjo.2015.12.023 · Cited by 3
Gohari, M., Moghimi, M., Aarafi, H., Shajari, A., Nedooshan, J. J., Lookzadeh, M. H., Mirjalili, S. R., & Neámatzadeh, H. (2020) · Fetal and Pediatric Pathology · doi:10.1080/15513815.2020.1721738 · Cited by 5
“Studies have been reported that there is a significant association between some genetic factors, such as MDM2, MDM4, TP53, MTHFR and MTR polymorphisms, and susceptibility to retinoblastoma [17,18].”
BackgroundHashimoto, K., Kumagai, T., Nomura, K., Miyagawa, Y., Tago, S., Takasaki, K., Takahashi, Y., Nishida, H., Ichinose, T., Hirano, M., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-44273-6 · Cited by 6
Retinoblastoma caused by an RB1 variant with unusually low penetrance in a Danish family
Gregersen, P. A., Jensen, P. S., Christensen, R., Lohmann, D. R., Racher, H., Gallie, B. L., & Urbak, S. F. (2024) · European Journal of Medical Genetics · doi:10.1016/j.ejmg.2024.104956 · Cited by 3
Self-citationHistopathological Characteristics and Classification for Prognostic Indicators
Alsharif, H. M., Helmi, H., & Maktabi, A. M. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.89410 · Cited by 3
Resistant retinoblastoma in a 23-year-old patient
Mehyar, M., Yousef, Y. A., Istetieh, J., Nawaiseh, I., Al-Hussaini, M. A., Alrawashdeh, K., Jaradat, I., & Sultan, I. Y. (2014) · Oman Journal of Ophthalmology · doi:10.4103/0974-620x.142597 · Cited by 3
“[11] 12-14] It carries RB1 gene mutation causing genome instability making it premalignant lesion [12,15] that requires close observation due to the risk of malignant transformation to retinoblastoma, and genetic testing and counseling is needed if available.”
Rare Tumors: An Eye on the Future
Sagoo, M. S., Filipović, A., Harby, L. A., & Stebbing, J. (2015) · Future Oncology · doi:10.2217/fon.15.212 · Cited by 3
Retinocytoma: understanding pathogenesis, diagnosis, and treatment approaches
Al-Hussaini, M. A., Sharie, S. A., Sultan, H., Mohammad, M. T., & Yousef, Y. A. (2025) · International Journal of Retina and Vitreous · doi:10.1186/s40942-025-00642-z · Cited by 2
“A study by Dimaras et al. observed that retinomas, with their high expression of senescence-associated proteins like p16INK4a and p130, exhibit low-level genomic instability [62].”
InfluentialSecond Malignancies in Retinoblastoma: The Real Problem
Williams, B. K., & Amy, C. (2012) · InTech eBooks · doi:10.5772/30664 · Cited by 2
“These lesions display inactivations of both RB1 allelles and represent a step towards retinoblastoma development (Dimaras et al., 2008; Sampieri et al., 2008).”
BackgroundGarcía, R., Timmons, C. F., Luu, H. S., Miller, V., Fuda, F. S., Chen, W., & Koduru, P. R. K. (2022) · Cancer Genetics · doi:10.1016/j.cancergen.2022.09.009 · Cited by 2
Multimodal imaging in sporadic retinocytoma
Sabir, M., Jha, P., Chawla, R., & Shaikh, N. F. (2023) · BMJ Case Reports · doi:10.1136/bcr-2022-252260 · Cited by 2
“3 7–9 Recent genetic analysis of patients with retinocytoma, however, suggests mutated RB1 gene-induced genomic field instability with high expression of senescence-associated proteins as the mutations underpinning the benign attribute of retinocytoma.”
BackgroundDrakaki, Ε., Stavros, S., Konstantinou, F., Mavrogianni, D., Αντωνοπούλου, Μ., Drakakis, P., & Vlastos, D. (2024) · Hellenic Journal of Obstetrics and Gynecology · doi:10.33574/hjog.0556 · Cited by 2
Singh, A. D., McClintic, J. I., Balmer, A., & Munier, F. L. (2014) · Springer eBooks · doi:10.1007/978-3-662-43451-2_7 · Cited by 2
“Histopathologic analysis of eyes enucleated for retinoblastoma reveals the presence of retinocytoma or retinoma adjacent to both normal retina and in up to 16 % of retinoblastoma tumors [ 12 ].”
BackgroundMarx, M., Lebuhotel, C., Laugier, D., Chapelle, A., Calothy, G., & Saule, S. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.03.015 · Cited by 2
Retinoblastoma beyondRB1: recent advances in genetic biomarkers
Pentimalli, F., Indovina, P., & Giordano, A. (2010) · Expert Review of Ophthalmology · doi:10.1586/eop.10.75 · Cited by 2
Bilateral Retinoblastoma Presenting With Unilateral Phthisis
Maka, E., Csákány, B., & Tóth, J. (2009) · Journal of Pediatric Ophthalmology & Strabismus · doi:10.3928/01913913-20091118-06 · Cited by 2
Soliman, S. E., Méndez-Martínez, S., Nicola, M. L. D., Kiehl, R., & Krema, H. (2020) · Ophthalmic Genetics · doi:10.1080/13816810.2020.1765398 · Cited by 2
“For example, MDM4 gain may be involved in early transition of normal retina to retinoma, while progressive MYCN and E2F3 gain may drive progression to retinoblastoma(17), confirming the current assumption of pre-malignant nature of retinoma (18,19).”
BackgroundBisht, S., Chawla, B. V., & Dada, R. (2020) · Advances in Ophthalmology and Optometry · doi:10.1016/j.yaoo.2020.05.002 · Cited by 4
Galetzka, D., Böck, J., Dittrich, M., Sinizyn, O., Ludwig, M., Rossmann, H., Spix, C., Radsak, M., Radsak, M. P., Scholz-Kreisel, P., et al. (2022) · EXCLI journal · doi:10.17179/excli2021-4482 · Cited by 4
“Most retinoblastomas, which are derived from the cone photoreceptor lineage, show biallelic inactivation of the RB1 tumor suppressor gene, but additional (epi)genetic changes are most likely required for tumor development (Dimaras et al., 2008).”
BackgroundFath, M. K., Benam, S. P., Esfahani, N. K., Shahkarami, N., Shafa, S., Bagheri, H., Shafagh, S.-G., Payandeh, Z., & Barati, G. (2023) · Clinical & Translational Oncology · doi:10.1007/s12094-023-03144-2 · Cited by 2
“The second loss of function mutation in another RB1 allele (RB1−/−) causes limited retinal cell proliferation and develops a non-malignant retinoma [6].”
BackgroundLópez-Ansio, M., Ramos‐García, P., & González‐Moles, M. Á. (2023) · Cancers · doi:10.3390/cancers15123132 · Cited by 5
Case Report: Adult Retinoblastoma Progression in 19 Months
Zhou, L., Zhu, X., Zhang, K., Hu, R., & Myers, F. L. (2020) · Optometry and Vision Science · doi:10.1097/opx.0000000000001602 · Cited by 2
Clinical Features, Diagnosis, Pathology
Chévez‐Barrios, P., & Gombos, D. S. (2009) · Pediatric oncology · doi:10.1007/978-0-387-89072-2_3 · Cited by 2
Retinoblastoma: The Prototypic Hereditary Tumor
Dimaras, H., & Gallie, B. L. (2008) · Wiley eBooks · doi:10.1002/9783527627523.ch7 · Cited by 2
Self-citationPathology of the Retina and Vitreous
Wilson, D. J., Sahel, J., Brini, A., & Albert, D. M. (2008) · Elsevier eBooks · doi:10.1016/b978-1-4160-0016-7.50276-9 · Cited by 2
Belikov, A. V., Vyatkin, A. D., & Leonov, S. V. (2017) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/231027 · Cited by 2
“For example, it was shown that inactivation of both alleles of RB1 leads first to retinoma, a benign tumour with genomic instability that easily transforms to retinoblastoma upon acquiring additional mutations (26).”
BackgroundGenetics of the Pathophysiology of Retinoblastoma
Lohmann, D. R., & Gallie, B. L. (2018) · Wiley eBooks · doi:10.1002/9780470015902.a0006053.pub3 · Cited by 2
Self-citationLohmann, D. R., & Gallie, B. L. (2011) · Wiley eBooks · doi:10.1002/9780470015902.a0006053.pub2 · Cited by 3
Self-citationRetinoblastoma Protein, Biological and Clinical Functions
Dimaras, H., & Gallie, B. L. (2011) · Springer eBooks · doi:10.1007/978-3-642-16483-5_5069 · Cited by 1
Self-citationRetinoma — the first identified case in Jordan
Nazzal, R. M., Yousef, Y. A., Nowomiejska, K., & Ręjdak, R. (2019) · Ophthalmology Journal · doi:10.5603/oj.2019.0007 · Cited by 1
“RB1 alleles, absence of proliferative markers, low level of genomic instability and high expression of the senescence-associated proteins; while retinoblastomas, on the other hand, show reduced expression of senescence-associated proteins and increased genomic changes, indicating progression from retinoma; which means…”
BackgroundSTUDY OF RETINOBLASTOMA PENETRANCE AND PHENOTYPE
Kazubskaya, T. P., Alekseeva, Y., Ushakova, T. L., Yarovaya, V. А., Trofimov, Y., Mikhaylova, S. V., Lyubchenko, L. N., Козлова, В. М., & Strelnikov, V. V. (2018) · Voprosy Onkologii · doi:10.37469/0507-3758-2018-64-2-234-241 · Cited by 1
Toumasis, P. N., Mallipatna, A. C., Corson, T. W., & Dimaras, H. (2025) · Pediatric Investigation · doi:10.1002/ped4.12472 · Cited by 2
“2,3,21 The fact that retinoma and retinoblastoma do not arise from separate areas of the retina supports the idea that retinoblastoma represents the ultimate malignant stage in a series of clonal developments from normal to benign to malignant cells in the context of biallelic RB1 loss.”
InfluentialSelf-citationSpatial transcriptomics of retinoblastoma: a visual window on intra-patient heterogeneity
Moulin, A., Thevenet, J., Mazzeo, L., Tissot, S., Stathopoulos, C., Munier, F. L., & Berger, A. (2025) · BMC Cancer · doi:10.1186/s12885-025-14814-5 · Cited by 1
“The evaluation of human embryonic retinal explants has suggested that the initial proliferative state occurred during cone maturation, followed later by an indolent phase which might lead to either retinocytoma (benign tumor) or retinoblastoma (malignant tumor) development [6, 7].”
InfluentialTseng, P., Sinenko, I. L., Chambon, M., Banfi, D., Zugbi, S., Cancela, M. B., Glinkina, K. A., Turcatti, G., Stathopoulos, C., Schaiquevich, P. S., et al. (2026) · PLoS ONE · doi:10.1371/journal.pone.0339334 · Cited by 1
“Loss of the tumor-suppressive functions of the RB protein leads to uncontrolled cell division and recurrent genomic changes during tumor progression [6].”
KIF14 (kinesin family member 14)
Thériault, B., & Corson, T. W. (2011) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/38552 · Cited by 1
“KIF14 mRNA level increases with the progression from normal retina to benign retinoma to retinoblastoma (Dimaras et al., 2008).”
Self-citationHot Issues in The Current Management of Eye Cancer
Kivelä, T. (2009) · Future Oncology · doi:10.2217/fon.09.141 · Cited by 1
Clinical Genetics of Retinoblastoma: An Asian Perspective
Mallipatna, A. C., Marino, M. J., & Singh, A. D. (2017) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-4-431-56511-6_17 · Cited by 1
Roberts, F., & Thum, C. K. (2013) · Springer eBooks · doi:10.1007/978-1-4471-2476-4_5 · Cited by 1
Multimodal imaging of a unilateral large retinoma
Matet, A., Kaspi, M., & Garcin, T. (2022) · Journal Français d Ophtalmologie · doi:10.1016/j.jfo.2021.06.019 · Cited by 1
Milman, T. (2010) · Yearbook of Ophthalmology · doi:10.1016/s0084-392x(09)79198-1 · Cited by 1
Retinoblastoma and Simulating Lesions
Yanoff, M., & Sassani, J. W. (2019) · Elsevier eBooks · doi:10.1016/b978-0-323-54755-0.00018-8 · Cited by 1
Genetics of Retinoblastoma for Patients and Their Families
Sang, C. L. P., Jessen, J. L., Racher, H., & Gallie, B. L. (2019) · Springer eBooks · doi:10.1007/978-981-15-0395-5_2 · Cited by 1
Self-citationParulekar, M., & Gallie, B. L. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-813944-8.00025-1 · Cited by 1
Self-citationPathology of the Retina and Vitreous
Wilson, D. J., Sahel, J., Brini, A., & Albert, D. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-42634-7_133 · Cited by 1
Retinoblastoma: the evidence does matter.
Prigoda, N. L., Rushlowa, D., Piovesan, B., Zhang, K., Dimaras, H., Pajovic, S., & Gallie, B. L. (2009) · PubMed Central · doi:10.3233/clo-2009-0475 · Cited by 1
Self-citationSisley, K. (2010) · doi:10.1002/9781118010136.ch20 · Cited by 1
Correction: Genetic Variations Strongly Influence Phenotypic Outcome in the Mouse Retina
Jelcick, A. S., Yuan, Y., Leehy, B. D., Cox, L. C., Silveira, A. C., Qiu, F., Schenk, S., Sachs, A. J., Morrison, M. A., Nystuen, A., et al. (2011) · PLoS ONE · doi:10.1371/annotation/f375292d-9fc7-4e3c-9dc7-af0aee76fa15 · Cited by 1
Retinoblastoma Protein, Biological and Clinical Functions
Dimaras, H., & Gallie, B. L. (2015) · Springer eBooks · doi:10.1007/978-3-642-27841-9_5069-9 · Cited by 1
Self-citationKarhemo, P. (2013) · Helda - University of Helsinki Institutional Repository
Retinoblastoma – to expand awareness
Wainwright, R. (2010) · CME/Continuing medical education
Retinoma and Retinoblastoma: Genomic Hybridisation
Amenduni, M., Livide, G., Ariani, F., & Renieri, A. (2012) · Springer eBooks · doi:10.1007/978-94-007-4213-0_10
Dimaras, H. (2012) · Atlas of Genetics and Cytogenetics in Oncology and Haematology · doi:10.4267/2042/47543
“Adjacent specimens of retinoblastoma and retinoma display the same mutation(s) in RB1 (Dimaras et al., 2008).”
BackgroundInfluentialSelf-citationClinical pathologic conference case 1: Three week history of painless swelling of the right mandible
Afrogheh, A., Hille, J. J., Sadow, P. M., & Faquin, W. C. (2015) · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology · doi:10.1016/j.oooo.2014.11.004
Evolución natural de los tumores renales: fundamento teórico y papel de la vigilancia activa
Jewett, M. A. S., & Zúñiga, Á. (2008) · Clínicas urológicas de Norteamérica
CONSTITUTIVE AND SOMATIC GENETIC EVENTS IN RETINOMA AND RETINOBLASTOMA
Sampieri, K. (2008)
We need to be more aware of retinoblastoma.
Wainwright, R., & Kruger, M. (2010)
GENOMIC CHARACTERIZATION OF RECURRENT CHROMOSOMAL ABERRATIONS IN RETINOBLASTOMA
D'Silva, C. N. (2010)
Opini O n Mini FO cus: Ophthal MO l O gy
Basavarajappa, H. D. (2012)
a potential mechanism compromising the p53 response during retinoblastoma development
To, K.-H., Pajovic, S., Gallie, B. L., & Thériault, B. L. (2012)
Self-citationRetinoblastoma and the RB1 Cancer Syndrome
Murphree, A. L., Clark, R. D., Randolph, L. M., Sachdeva, U. M., Gombos, D. S., & O’Brien, J. M. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-383834-6.00149-x
Genetics of Retinoblastoma and Genetic Counseling
Dimaras, H., & Gallie, B. L. (2009) · Pediatric oncology · doi:10.1007/978-0-387-89072-2_4
Self-citationCoordinating Cell Cycle Exit and Differentiation in the Mammalian Retina and its Dependence on Rb
Pacal, M. (2012) · TSpace (University of Toronto)
A Subset of Retinoblastoma Lacking RB1 Gene Mutations have High-level MYCN Gene Amplification
Yee, S. S. (2010) · TSpace (University of Toronto)
Current Assessment and Management of Retinoblastoma
Chueh, H. W. (2019) · Imsang soa hyeoraek jong-yang/Imsang soa hyeol'aeg jong'yang/Clinical pediatric hematology-oncology · doi:10.15264/cpho.2019.26.1.35
“These mechanisms are also closely related to other oncogenes or tumor-suppressor genes; gained copies of DEK oncogenes, NUP153, E2F3, TTRAP, copy number variation of MYCN oncogenes are recently discovered cytogenetic lesions in retinoblastoma [4,6,7].”
BackgroundOliveira, D. V. C. (2018) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.42.2019.tde-18022019-101454
The Tumor Microenvironment Regulates Retinoblastoma Cell Survival
Goldsmith, Z. K. (2018) · doi:10.21007/etd.cghs.2018.0472
Pathology of Intraocular Tumors
Krishnakumar, S. (2019) · Springer eBooks · doi:10.1007/978-981-15-0395-5_9
Oncologic Properties of Retinoblastoma Genes
Chu, W. K., Yam, J. C. S., Chen, L. J., & Pang, C. P. (2021) · Essentials in ophthalmology/Essentials ophthalmology · doi:10.1007/978-981-15-9184-6_27
Zhang, J., Liu, Z., & Deng, G. (2021) · Journal of Oncology · doi:10.1155/2021/9403333
Sagar, P., & Shanmugam, M. P. (2022) · Springer eBooks · doi:10.1007/978-981-16-4247-0_8
(2008) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e328317c7c4
Roberts, F., & Thum, C. K. (2021) · Springer eBooks · doi:10.1007/978-3-030-76525-5_5
Bechrakis, N. E., Luthert, P. J., & Wilson, D. J. (2014) · Springer eBooks · doi:10.1007/978-3-662-43382-9_9
Metadata
- Authors
- Dimaras, H., Khetan, V., Halliday, W., Orlic, M., Prigoda, N. L., Piovesan, B., Marrano, P., Corson, T. W., Eagle, R. C., Squire, J. A., & Gallie, B. L.
- Affiliations
- University of Toronto (CA)
- Hospital for Sick Children (CA)
- University Health Network (CA)
- Princess Margaret Cancer Centre (CA)
- Wills Eye Hospital (US)
- Corresponding author
- Gallie, Brenda L.
- Venue
- Human Molecular Genetics
- Publisher
- Oxford University Press (OUP)
- Published
- 2008-01-22
- Volume
- 17
- Issue
- 10
- Pages
- 1363-1372
- ISSN
- 0964-6906 (ISSN-L)
- 1460-2083
- OpenAlex
- W2122129374
- Cited by
- 351
- References
- 48
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 20 · 2023: 15 · 2022: 24 · 2021: 36 · 2020: 19 · 2019: 19 · 2018: 16 · 2017: 14 · 2016: 12 · 2015: 23 · 2014: 14 · 2013: 20 · 2012: 19
- FWCI
- 24.65
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Molecular Genetics (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Ophthalmology › Ocular Oncology and Treatments
- Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Keywords
- retinoblastoma, retinoma, genomic instability, cellular senescence, p16INK4a, p130, two-hit model, tumor suppressor, oncogene expression, aneuploidy, MYCN, E2F3, DEK, KIF14, MDM4, cadherin-11, p75 neurotrophin receptor, retinal development, tumor progression
- MeSH terms
- Adult, Gene Amplification, Homozygote, Humans, Infant, Male, Retinoblastoma, Oncogene Proteins, Tumor Suppressor Protein p53, Retinoblastoma Protein, Disease Progression, Gene Dosage, Proliferating Cell Nuclear Antigen, Ki-67 Antigen, Cyclin-Dependent Kinase Inhibitor p16, Gene Silencing, Tumor Suppressor Proteins, Genomic Instability, Cell Proliferation, Retinoblastoma-Like Protein p130
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.